20
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T82246 |
H7
|
||
H7为第二型近红外(NIR-II)荧光团。 | |||
T7501 |
Iso-H7 dihydrochloride
1-(5-硫代异喹啉)-3-甲基哌嗪二盐酸盐 |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
与 H-7 相比,Iso-H7 dihydrochloride 是一种较弱的磷酸激酶 C 抑制剂。 | |||
T22831 |
Protein kinase inhibitor H-7 dihydrochloride
H-7 dihydrochloride |
PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Protein kinase inhibitor H-7 dihydrochloride(H-7 dihydrochloride0) 是一种有效的蛋白激酶 C(PKC)抑制剂。Protein kinase inhibitor H-7 dihydrochloride(100 μM)显著抑制 TPA (皮肤肿瘤启动子,12-O-tetradecanoylphorbol-13-acetate) 和磷脂酶 C 促使的 ODC (鸟氨酸脱羧酶),抑制 PMA 诱导的混杂细胞溶解活性。 | |||
T3599 |
BFH772
BFH-722 |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
BFH772 是 VEGFR2抑制剂(IC50:3 nM),具有口服活性。 | |||
T12870 |
SCH79797 dihydrochloride
|
Apoptosis; Others; Protease-activated Receptor | Apoptosis; GPCR/G Protein; Others |
SCH79797 dihydrochloride 是一种有效的特异性蛋白酶激活受体 1 (PAR1) 拮抗剂,IC50 为 70 nM,Ki 为 35 nM。SCH79797 dihydrochloride 具有抗增殖和促凋亡作用。 | |||
T5635 |
CH7057288
|
Trk receptor | Tyrosine Kinase/Adaptors |
CH7057288 是选择性TRK 抑制剂。 | |||
T6960L |
PU-H71 HCl
PU-H71 HCl(873436-91-0 Free base),Zelavespib HCl |
HSP; DNA/RNA Synthesis | Cell Cycle/Checkpoint; Cytoskeletal Signaling; DNA Damage/DNA Repair; Metabolism |
PU-H71 HCl (Zelavespib HCl) 是一种新型Hsp90抑制剂,是一种新型嘌呤基类似物,也是一种可能是CIRT的一种有前途的放射增敏剂。PU-H71 HCL 在许多恶性肿瘤临床前模型中显示出抗肿瘤活性。PU-H71 HCL 对 Rad51 和Ku70 的蛋白表达水平有抑制作用,这可能与双链断裂修复的同源重组途径和非同源末端连接途径有关。 | |||
T15658 |
KH7
|
cAMP; AChR | GPCR/G Protein; Neuroscience |
KH7 是腺苷酸环化酶 (sAC) 特异性的可溶性抑制剂,也是一种 cAMP 抑制剂。它对重组纯化的人类 sACt 蛋白和细胞试验中异源表达的 sACt 的 IC50 为 3 到 10 μM 之间。 | |||
T6066 |
SCH772984
|
ERK; MEK | MAPK |
SCH772984 是高选择性和 ATP 竞争性ERK 抑制剂,对 ERK1 和 ERK2 的IC50分别为 4 和 1 nM。它在含有 BRAF 或 RAS 突变的 MAPK 抑制剂初治和 MAPK 抑制剂耐药细胞中具有抗肿瘤活性。 | |||
T6960 |
PU-H71
|
HSP | Cytoskeletal Signaling; Metabolism |
PU-H71是一种选择性的HSP90抑制剂,IC50= 51 nM。 | |||
T71247 |
PU-H71 hydrate
|
||
PU-H71 hydrate is a potent inhibitor of heat shock protein 90 (Hsp90). | |||
T23338 |
SCH772984 TFA (942183-80-4 free base)
SCH772984 TFA |
Others | Others |
ERK1/2 inhibitor | |||
T28734 |
SCH79797
SCH 79797,SCH-79797 |
||
SCH-79797 is a potent and selective PAR1 antagonist. | |||
T23337 |
SCH772984 HCl
|
ERK; Others | MAPK; Others |
SCH772984 HCl 是一种特异性的 ERK1/2 抑制剂,具有 I 型和 II 型激酶抑制剂的特性,其 IC50 分别为 4 和 1 nM。 SCH772984 HCl 在 BRAF、NRAS 或 KRAS 突变的肿瘤细胞中具有纳摩尔级细胞效力,并诱导肿瘤消退。 SCH772984 HCl 可用于 MAPK 抑制剂难治性肿瘤的研究。 | |||
T27523 |
H77-77
H77/77 |
||
H77-77, a monoamine oxidase (MAO) inhibitor, produces a pronounced protection against phenelzine within the serotonergic and noradrenergic neurons in rats. | |||
T64714 |
10× TBS (PH7.4)
|
||
10× TBS (PH7.4) 是一种试剂,在生命科学相关研究中具有广泛的应用。 | |||
T35334 | CH7233163 | EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
CH7233163 是一种EGFR-tyrosine kinase 的非共价ATP 竞争性抑制剂,对有EGFR-Del19/T790M/C797S 的肿瘤具有抗肿瘤活性。 | |||
T69513 |
(–)-IHCH7041
|
||
(–)-IHCH7041 is a optical rotation negative isomer of IHCH7041. (–)-IHCH7041 is a DRD2 partial agonist. (–)-IHCH7041 showed EC50 = 1.38 nM in Gαi1–γ9 dissociation and 2.75 nM in β-arrestin2 recruitment. (–)-IHCH7041 exhibited a inhibition constant (Ki) of 22.44 nM binding affinity at DRD2. (–)-IHCH7041 has antidepressant properties and reverses cognitive impairment. | |||
T69512 |
IHCH7041
|
||
IHCH7041, also known as (+/-)-IHCH7041, is a DRD2 partial agonist. IHCH7041 contains two enantiomers: (-)-IHCH7041 and (+)-IHCH7041 (optical rotation negative and positive). (+/-)-IHCH7041 has CAS#2813335-29-2. Two isomers have CAS#2813335-07-6 (rotation negative) and 2813335-06-5 (rotation positive), respectively. | |||
T26579 |
AHU1
|
||
AHU1 is a blocker of Shiga Toxin expression in Escherichia coli O157:H7. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T80357 |
Bombinin H7
|
||
Bombinin H7 是一种抗菌肽,提取自铃蟾Bombina的皮肤分泌物。该化合物对Bacillus megateriumBm11显示出高效活性,其致死浓度达到25.2 μM。 | |||
T81845 | Maximin H7 | ||
Maximin H7为源自Bombina maxima蟾蜍的抗菌肽。 | |||
TN1687 |
Ginsenoside Rh7
人参皂苷 RH7 |
Others | Others |
Ginsenoside Rh7 is a natural product | |||
T6S2116 |
Ginkgolic acid C17:1
银杏酸 C17:1,银杏酸C17:1 |
Phosphatase; PTEN | Metabolism; PI3K/Akt/mTOR signaling |
Ginkgolic acid C17:1 是分离自银杏叶中,通过诱导PTEN 和SHP-1酪氨酸磷酸酶抑制组成型和诱导型 STAT3 活化。它具有抗癌活性。 |